1. Home
  2. AVXL vs HZO Comparison

AVXL vs HZO Comparison

Compare AVXL & HZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • HZO
  • Stock Information
  • Founded
  • AVXL 2004
  • HZO 1998
  • Country
  • AVXL United States
  • HZO United States
  • Employees
  • AVXL N/A
  • HZO N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • HZO Auto & Home Supply Stores
  • Sector
  • AVXL Health Care
  • HZO Consumer Discretionary
  • Exchange
  • AVXL Nasdaq
  • HZO Nasdaq
  • Market Cap
  • AVXL 635.6M
  • HZO 604.0M
  • IPO Year
  • AVXL N/A
  • HZO 1998
  • Fundamental
  • Price
  • AVXL $3.71
  • HZO $22.95
  • Analyst Decision
  • AVXL Strong Buy
  • HZO Strong Buy
  • Analyst Count
  • AVXL 3
  • HZO 4
  • Target Price
  • AVXL $33.00
  • HZO $34.00
  • AVG Volume (30 Days)
  • AVXL 2.9M
  • HZO 356.6K
  • Earning Date
  • AVXL 12-22-2025
  • HZO 11-13-2025
  • Dividend Yield
  • AVXL N/A
  • HZO N/A
  • EPS Growth
  • AVXL N/A
  • HZO N/A
  • EPS
  • AVXL N/A
  • HZO N/A
  • Revenue
  • AVXL N/A
  • HZO $2,309,288,000.00
  • Revenue This Year
  • AVXL N/A
  • HZO N/A
  • Revenue Next Year
  • AVXL N/A
  • HZO $3.85
  • P/E Ratio
  • AVXL N/A
  • HZO N/A
  • Revenue Growth
  • AVXL N/A
  • HZO N/A
  • 52 Week Low
  • AVXL $2.86
  • HZO $16.85
  • 52 Week High
  • AVXL $14.44
  • HZO $35.46
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 14.26
  • HZO 39.90
  • Support Level
  • AVXL $6.35
  • HZO $21.70
  • Resistance Level
  • AVXL $7.25
  • HZO $24.79
  • Average True Range (ATR)
  • AVXL 0.64
  • HZO 1.45
  • MACD
  • AVXL -0.34
  • HZO -0.19
  • Stochastic Oscillator
  • AVXL 14.49
  • HZO 20.97

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

Share on Social Networks: